A University of Colorado professor won the 2024 Alton Ochsner Award for his work on disease risk factors for idiopathic ...
ECMO or ventilator use was the most significant predictor of mortality in patients undergoing lung transplant for idiopathic ...
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...
Fast Track Designation is available to drugs that may provide an advantage over current therapies in the treatment of serious conditions. It is designed to speed the development o ...
A biotech that uses artificial intelligence to assist its drug discovery efforts has relocated its headquarters from New York ...
2d
HIGHLIGHTS The US FDA has granted Fast Track Designation to Amplia's lead drug narmafotinib in advanced pancreatic cancer Fast Track Designation facilitates the development of investigational drugs an ...
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute ...
The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...
COVID-19 has no impact on BMI trajectory or lung function in people with cystic fibrosis in the year following infection.
The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback